Page last updated: 2024-10-18

dihydroxyphenylalanine and Brain Stem Neoplasms, Primary

dihydroxyphenylalanine has been researched along with Brain Stem Neoplasms, Primary in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshimura, M1
Yamamoto, T1
Iso-o, N1
Imafuku, I1
Momose, T1
Shirouzu, I1
Kwak, S1
Kanazawa, I1

Other Studies

1 other study available for dihydroxyphenylalanine and Brain Stem Neoplasms, Primary

ArticleYear
Hemiparkinsonism associated with a mesencephalic tumor.
    Journal of the neurological sciences, 2002, May-15, Volume: 197, Issue:1-2

    Topics: Brain Stem Neoplasms; Carbon Radioisotopes; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine Agents

2002